CAHILL FINANCIAL ADVISORS INC

Position in PFE — Pfizer Inc

CIK 1600327 EDINA, MN

Position in PFE

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$324,911

-$62,256 QoQ

Shares Held

13,493

-2.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

#2,068

of 2,821 holders

Holding Since

Sep 2021

16 quarters on record

Voting authority Sole 18% Shared 0% None 82%

Healthcare · as of Jun 30, 2026

CAHILL FINANCIAL ADVISORS INC holds $3,643,630 across 6 Drug Manufacturers - General names. PFE ranks #6 (8.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	4,966	$1,261,215
2	ABBV	AbbVie Inc.	2,753	$692,764
3	MRK	Merck & Co., Inc.	4,446	$571,311
4	GILD	Gilead Sciences, Inc.	3,540	$447,243
5	AMGN	Amgen Inc	956	$346,186
6	PFE	Pfizer Inc This page	13,493	$324,911

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$324,911	13,493	-2.1%	Shares	Sole	2026-08-11
2026-03-31	$387,167	13,788	-0.7%	Shares	Sole	2026-05-13
2025-12-31	$345,686	13,883	-37.7%	Shares	Sole	2026-02-18
2025-09-30	$567,796	22,284	+2.4%	Shares	Sole	2025-11-03
2025-06-30	$527,632	21,767	+23.1%	Shares	Sole	2025-08-07
2025-03-31	$448,011	17,680	+15.7%	Shares	Sole	2025-05-15
2024-12-31	$405,484	15,284	+60.4%	Shares	Sole	2025-02-14
2024-09-30	$275,740	9,528	+1.7%	Shares	Sole	2024-11-12
2024-06-30	$262,060	9,366	-2.7%	Shares	Sole	2024-08-07
2024-03-31	$267,093	9,625	+12.9%	Shares	Sole	2024-05-13
2023-12-31	$245,405	8,524	-11.5%	Shares	Sole	2024-02-14
2023-09-30	$319,526	9,633	+24.9%	Shares	Sole	2023-11-14
2023-06-30	$282,912	7,713	+4.4%	Shares	Sole	2023-08-14
2023-03-31	$301,430	7,388	+43.4%	Shares	Sole	2023-05-12
2022-12-31	$264,039	5,153	+282.0%	Shares	Sole	2023-02-15
2021-09-30	$58,019	1,349	—	Shares	Other	2021-11-16
No filing history on record for this holder in this stock.